BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• BioCapital

  W. R. Grace & Company Introduces Disposable Purification Solution To Lower Cost And Accelerate Drug Development For Biotech

  March 24, 2014

   · 

  1 min read
• Business

  Safeguard Scientifics To Release First Quarter 2014 Financial Results On Thursday, April 24th

  March 24, 2014

   · 

  1 min read
• FDA

  Taiho Pharmaceutical’s Lonsurf® (Trifluridine And Tipiracil Hydrochloride) Tablets Approved In Japan For Treatment Of Advanced Metastatic Colorectal Cancer

  March 24, 2014

   · 

  2 min read
• Drug Development

  Ariad Pharmaceuticals, Inc. Announces Initiation Of Pivotal Phase 2 ALTA Trial Of AP26113 In Patients With Non-Small Cell Lung Cancer

  March 24, 2014

   · 

  1 min read
• Drug Development

  Merck & Co., Inc. To Present New Data For Investigational Hepatitis C Treatments MK-5172 And MK-8742 At EASL Annual Meeting/The International Liver Congress™ 2014

  March 24, 2014

   · 

  1 min read
• Drug Development

  Provectus Pharmaceuticals Inc. Submits Application To FDA To Receive Breakthrough Therapy Designation For PV-10 For Treatment Of Melanoma

  March 24, 2014

   · 

  1 min read
• BioMidwest

  St. Jude Medical Announces Global Launch Of Optisure Defibrillation Lead

  March 24, 2014

   · 

  1 min read
• Biotech Beach

  Metactive Debuts Novel Embolization Technology With Presentation At The Society Of Interventional Radiology’s Annual Scientific Meeting

  March 24, 2014

   · 

  1 min read
• Drug Development

  Bristol-Myers Squibb Company To Present Data For Daclatasvir In Multiple Investigational All-Oral Combinations Across Hepatitis C Genotypes At The International Liver Congress™

  March 24, 2014

   · 

  1 min read
• Drug Development

  CytRx Corporation Initiates Pivotal Global Phase 3 Clinical Trial With Aldoxorubicin For Second-Line Treatment Of Soft Tissue Sarcoma

  March 24, 2014

   · 

  1 min read